Received: 10 March 2022
Accepted: 26 May 2022
First Online: 2 June 2022
: This study was executed under ethical approval from the Medical Research Center, Hamad Medical Corporation, Doha, Qatar (Protocol no. MRC-02–18-012). The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Qatar Biomedical Research Institute. Written informed consent was obtained from all subjects and/or their legal guardian(s) for study participation.
: Informed consent for publication was obtained from all subjects involved in the study.
: The authors declare no conflicts of interest.